Intellectual Disability in KATP Channel Neonatal Diabetes

Pernille Svalastoga1,2, Åsta Sulen1, Jarle R Fehn3

  • 1Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway.

Diabetes Care
|January 15, 2020
PubMed

Insights

The p.V59M genotype in KATP channel neonatal diabetes is linked to significant intellectual disability. This finding impacts understanding of treatment benefits and neuropsychiatric risks in affected children.

Area of Science:

  • Endocrinology
  • Genetics
  • Neuroscience

Background:

  • Neonatal diabetes mellitus (NDM) is linked to neuropsychiatric issues.
  • The precise impact of specific NDM mutations on intellectual functioning remains unclear.
  • Limited data exists for NDM patients with developmental delay.

Purpose of the Study:

  • To comprehensively assess intellectual functioning and mental health in the Norwegian KATP channel NDM population.
  • To investigate genotype-phenotype correlations, particularly for the p.V59M mutation.
  • To evaluate the influence of sulfonylurea treatment timing on cognitive outcomes.

Main Methods:

  • Evaluated the complete Norwegian KATP channel NDM cohort.
  • Included eight sulfonylurea-treated children (five with p.V59M genotype).
  • Utilized developmental examinations, cerebral MRI, psychometric testing, and questionnaires compared to type 1 diabetes controls.

Main Results:

  • A strong genotype-phenotype correlation identified the p.V59M genotype with substantial intellectual disability.
  • Other genotypes were associated with minor cognitive impairment.
  • Cerebral MRI showed normal brain anatomy in most participants.

Conclusions:

  • The p.V59M genotype is strongly associated with significant intellectual disability in KATP channel NDM.
  • Intellectual disability complicates the interpretation of psychological measures and the perceived benefit of sulfonylurea.
  • This study found no evidence for an early treatment start benefit, though a weaker effect cannot be excluded.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
649
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
533
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.0K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.0K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K